Florida Cancer Specialists Welcomes Susmitha Apuri, MD
New Medical Oncologist/Hematologist Joining in Inverness
Fort Myers, FL – June 25, 2019 . . . Florida Cancer Specialists & Research Institute (FCS) is pleased to announce that Medical Oncologist/Hematologist, Susmitha Apuri, MD will be joining the statewide practice on July 1, 2019, and will be seeing patients in Inverness, (2231 Highway 44 West, Unit 203).
FCS CEO, Brad Prechtl, MBA said, “Dr. Apuri brings much needed expertise in medical oncology and hematology to the central Florida community of Inverness. We are pleased to have her join the FCS family.”
Dr. Lucio N. Gordan, President & Managing Physician of FCS, added, “We are pleased to welcome Dr. Apuri to Florida Cancer Specialists. She comes to us with excellent credentials and a demonstrated focus on clinical research, which is critical in providing the best care for our patients."
Board certified in medical oncology, hematology, and internal medicine, Dr. Susmitha Apuri earned her medical degree from NTR University of Health Sciences in Vijayawada, India. She completed her internship and residency in internal medicine at the University of Miami Miller School of Medicine and her fellowship in hematology/oncology at the University of South Florida/H. Lee Moffitt Cancer and Research Institute in Tampa, Florida. Her research and practice interests include breast, lung and colorectal malignancies, malignant as well as non-malignant hematology.
Actively engaged in clinical trials, Dr. Apuri also served as a principal investigator in clinical trials involving advanced melanoma, breast cancer, and peripheral T-cell lymphoma. She was an Assistant Professor at Moffitt Cancer Center/University of South Florida and has been a co-investigator for multiple clinical trials.
Published in several peer-reviewed journals, Dr. Apuri has also co-authored various book chapters. Her research was presented at multiple national conferences, including The American Society of Clinical Oncology, American Society of Hematology, Society of Hematologic Oncology, and the Miami Breast Cancer Conference. She is fluent in Telugu and Hindi.
About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. In the past four years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Founded in 1984, FCS is one of the largest medical oncology/hematology practices in the United States. With more than 230 physicians, 220 advanced practice registered nurses (APRN) and physician assistants (PA) and nearly 100 locations in our network, we are committed to providing world-class cancer care in community-based settings.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help targeted treatments and genomic-based treatment and immunotherapy. These values are embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
*Prior to approval
For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer
(813) 281.0088 ext. 327
Ganick Communications, Inc.